Hualan Biological Engineering Inc. (SHE:002007)
China flag China · Delayed Price · Currency is CNY
11.73
+0.05 (0.43%)
Nov 17, 2026, 3:04 PM CST

SHE:002007 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
3,7874,5844,3665,3334,5034,426
Other Revenue
10.9310.9313.588.913.6710.31
3,7984,5954,3795,3424,5174,436
Revenue Growth
-10.99%4.93%-18.02%18.26%1.82%-11.69%
Cost of Revenue
2,0082,0131,7681,7271,6991,538
Gross Profit
1,7902,5822,6113,6152,8182,898
Selling, General & Admin
779.881,0401,0661,4651,2051,011
Research & Development
304.96337.46333.18280.84314.7253.63
Other Operating Expenses
53.8741.4638.3544.6241.7536.17
Operating Expenses
1,1511,4531,4321,8051,5951,312
Operating Income
639.531,1301,1791,8101,2231,586
Interest Expense
-4.96-10.24-12.95-13.17-30.27-21.72
Interest & Investment Income
104.7272.59157.95164.47128.9285.28
Currency Exchange Gain (Loss)
0.250.25-0.15-0.3-0.010.33
Other Non Operating Income (Expenses)
34.75-0.55-0.49-0.28-0.38-0.34
EBT Excluding Unusual Items
774.281,1921,3231,9611,3221,650
Gain (Loss) on Sale of Investments
10.5915.1732.9460.5436.1126.86
Gain (Loss) on Sale of Assets
-2.92.890.0844.4447.670.42
Asset Writedown
-2.7-3.53-5.71-9.71-1.19-3.23
Other Unusual Items
-58.99-32.77-11.8121.2424.1714.39
Pretax Income
720.281,1731,3392,0781,4281,688
Income Tax Expense
118.93173.36183.14315.96180.76234.13
Earnings From Continuing Operations
601.35999.991,1551,7621,2481,454
Minority Interest in Earnings
-14.77-59.59-67.62-280.11-171.34-155.22
Net Income
586.58940.41,0881,4821,0761,299
Net Income to Common
586.58940.41,0881,4821,0761,299
Net Income Growth
-38.16%-13.55%-26.57%37.66%-17.14%-19.48%
Shares Outstanding (Basic)
1,8241,8261,8261,8241,8251,821
Shares Outstanding (Diluted)
1,8241,8261,8291,8241,8281,831
Shares Change
-0.17%-0.16%0.23%-0.19%-0.17%0.59%
EPS (Basic)
0.320.520.600.810.590.71
EPS (Diluted)
0.320.520.590.810.590.71
EPS Growth
-38.06%-13.41%-26.75%37.92%-17.00%-19.95%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
618.63680.65803.92592.43563.36621.15
Free Cash Flow Per Share
0.340.370.440.330.310.34
Dividend Per Share
0.7001.0000.2000.3000.3000.200
Dividend Growth
0%400.00%-33.33%0%50.00%-33.33%
Gross Margin
47.14%56.19%59.62%67.67%62.38%65.33%
Operating Margin
16.84%24.58%26.92%33.89%27.08%35.76%
Profit Margin
15.44%20.47%24.84%27.73%23.83%29.28%
Free Cash Flow Margin
16.29%14.81%18.36%11.09%12.47%14.00%
EBITDA
923.471,4031,4392,0691,4961,783
EBITDA Margin
24.31%30.54%32.87%38.74%33.12%40.18%
D&A For EBITDA
283.95273.88260.46259.05272.5196.39
EBIT
639.531,1301,1791,8101,2231,586
EBIT Margin
16.84%24.58%26.92%33.89%27.08%35.76%
Effective Tax Rate
16.51%14.77%13.68%15.21%12.65%13.87%
Revenue as Reported
3,7984,5954,3795,3424,5174,436
Advertising Expenses
-5.425.086.312.843.38